Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 51–75 of 566 matching trials (filtered from 7,816) · page 3 of 23, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Exploring the Utility of [18F]3F4AP for Demyelination Imaging NCT06999434 [ 18F]3F4AP; [18F]MK6240; [11C]PIB Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 105 | Yale University OTHER |
2026-09-09 |
|
A Study of Psychedelics in Healthy Older Adults With Low Well-being NCT07386730 Psilocybin (drug); Dextromethorphan (DXM) Runs in: United States · 1 site |
PHASE1 other |
RECRUITING | 80 | Jennifer Mitchell OTHER |
2026-09-09 |
|
Alzheimer's Disease Genetics Study NCT00064870 Runs in: United States · 1 site |
NA other |
RECRUITING | 10,000 | Indiana University OTHER |
2026-09-08 |
|
Accelerated Age-related Cognitive Decline: Impact of Exercise on Executive Function and Neuroplasticity NCT05655325 Home-based walking exercise; Attention control Runs in: United States · 2 sites |
NA other |
RECRUITING | 144 | Columbia University OTHER |
2026-09-08 |
|
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders NCT05929703 HELP; FAM-HELP Runs in: United States · 7 sites |
NA other |
RECRUITING | 1,900 | University of Michigan OTHER |
2026-09-08 |
|
Prediction and Prevention of Postoperative Mortality and Morbidity NCT06042413 Personalized CPC Prehabilitation; Cognitive Training; Meditation; D... Runs in: United States · 5 sites |
NA other |
NOT_YET_RECRUITING | 1,200 | University of Pittsburgh OTHER |
2026-09-08 |
|
Alzheimer's Tau Platform: Master Protocol NCT06957418 AADvac1; Tau2 Runs in: United States · 3 sites |
PHASE2 other |
RECRUITING | 900 | Paul S. Aisen OTHER |
2026-09-08 |
|
Snacks and Brain Health NCT07348406 Pecan snack; Pretzel snack Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 60 | Texas Tech University Health Sciences Center OTHER |
2026-09-08 |
|
100-Year Human Aging Study NCT07563777 Comprehensive Multi-System Clinical Screening Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000,000 | Longevity Metrics, Inc. INDUSTRY |
2026-09-08 |
|
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) NCT07589595 Donanemab; Placebo Runs in: Japan; South Korea; Taiwan; United States · 72 sites |
PHASE2 anti-amyloid-antibody |
RECRUITING | 350 | Eli Lilly and Company INDUSTRY |
2026-09-08 |
|
Human Observatory Study NCT07646782 Multi-Domain Ecological and Clinical Data Linkage Runs in: United States · 1 site |
NA other |
RECRUITING | 1,000,000 | Longevity Metrics, Inc. INDUSTRY |
2026-09-08 |
|
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease NCT04123314 Psilocybin Runs in: United States · 1 site |
EARLY_PHASE1 other |
RECRUITING | 20 | Johns Hopkins University OTHER |
2026-09-04 |
|
Global Blood-Brain Barrier Disruption and Post-Stroke Cognitive Decline NCT05556395 Runs in: United States · 1 site |
NA other |
RECRUITING | 150 | Johns Hopkins University OTHER |
2026-09-04 |
|
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU) NCT05658913 AV-1451 Runs in: United States · 2 sites |
NA other |
RECRUITING | 100 | University of Pennsylvania OTHER |
2026-09-04 |
|
OTC Hearing Aid and MCI NCT06112860 Over the counter hearing aid; Communication Strategies Information/... Runs in: United States · 3 sites |
NA other |
RECRUITING | 50 | Northwestern University OTHER |
2026-09-04 |
|
A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2) NCT06126224 KarXT; Placebo Runs in: Belgium; Canada; Chile; China; Greece; Hungary; Mexico; P... · 154 sites |
PHASE3 other |
RECRUITING | 500 | Karuna Therapeutics, Inc., a Bristol Myers Squibb company INDUSTRY |
2026-09-04 |
|
Large-coil Parietal Repetitive Transcranial Magnetic Stimulation (rTMS) for Alzheimer Disease (AD) NCT06597942 TMS; Transcranial Magnetic Stimulation Sham Runs in: United States · 1 site |
PHASE1|PHASE2 other |
RECRUITING | 54 | University of California, Los Angeles OTHER |
2026-09-04 |
|
Olfactory Training in Mild Cognitive Impairment NCT06825403 Olfactory Memory Training; Visual Memory Training Runs in: United States · 1 site |
NA other |
RECRUITING | 30 | Jeffrey Motter OTHER |
2026-09-04 |
|
Remotely-supervised Neuromodulation in PPA NCT07260253 Lexical Retrieval Cascade Treatment; Remotely Supervised Transcrani... Runs in: United States · 2 sites |
NA other |
RECRUITING | 80 | Maya Henry OTHER |
2026-09-04 |
|
A Study of LY3439539 in Participants With Alzheimer's Disease NCT07598370 LY3439539 Runs in: Australia; New Zealand; Singapore; United States · 11 sites |
PHASE1 other |
RECRUITING | 30 | Eli Lilly and Company INDUSTRY |
2026-09-04 |
|
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD) NCT07636811 Mivelsiran; Placebo Runs in: Spain; United States · 3 sites |
PHASE2 other |
RECRUITING | 58 | Alnylam Pharmaceuticals INDUSTRY |
2026-09-04 |
|
An Open Label Dose Escalation Study of VY1706 in Participants With Early Alzheimer's Disease NCT07764146 VY1706 Low dose; VY1706 Mid dose; VY1706 High Dose; Anti-AAV9 Total... Runs in: United States · 1 site |
PHASE1 gene-therapy |
RECRUITING | 18 | Voyager Therapeutics INDUSTRY |
2026-09-04 |
|
ADRC Clinical Cohort (Alzheimer's Disease) NCT06703541 Runs in: United States · 1 site |
NA other |
RECRUITING | 500 | Duke University OTHER |
2026-09-03 |
|
Regulating Together for Intellectual Disability and Autism: A Group Behavioral Therapy for for Emotion Dysregulation NCT07624448 Regulating Together group therapy Runs in: United States · 1 site |
NA other |
RECRUITING | 10 | Children's Mercy Hospital Kansas City OTHER |
2026-09-03 |
|
Closed-Loop Brain Stimulation as a Potential Intervention for Cognitive Decline NCT05907343 Closed-loop TBS; Open-loop TBS Runs in: United States · 1 site |
NA other |
RECRUITING | 180 | University of Texas at Austin OTHER |
2026-09-02 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
Last updated
From the research library
The highest-scoring studies we hold on this subject, each summarized in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial